CGTX: FDA Agrees On Outcome
Cognition Therapeutics reaches alignment with FDA on vital aspects to support its new drug application for psychosis associated with dementia with Lewy bodies
FDA Agrees Psychosis Associated With Dementia With Lewy Bodies May Be Approvable Outcome, Reaches Alignment With Cognition Therapeutics On Vital Aspects To Support Its New Drug Application